BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ye L, Zhao D, Xu Y, Lin J, Xu J, Wang K, Ye Z, Luo Y, Liu S, Yang H. LncRNA-Gm9795 promotes inflammation in non-alcoholic steatohepatitis via NF-[Formula: see text]B/JNK pathway by endoplasmic reticulum stress. J Transl Med 2021;19:101. [PMID: 33750416 DOI: 10.1186/s12967-021-02769-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ming S, Tian J, Ma K, Pei C, Li L, Wang Z, Fang Z, Liu M, Dong H, Li W, Zeng J, Peng Y, Gao X. Oxalate-induced apoptosis through ERS-ROS-NF-κB signalling pathway in renal tubular epithelial cell. Mol Med 2022;28:88. [PMID: 35922749 DOI: 10.1186/s10020-022-00494-5] [Reference Citation Analysis]
2 Yin H, Shi A, Wu J. Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease. Diabetes Metab Syndr Obes 2022;15:2003-30. [PMID: 35837578 DOI: 10.2147/DMSO.S367483] [Reference Citation Analysis]
3 Ashrafizadeh M, Zarrabi A, Mostafavi E, Aref AR, Sethi G, Wang L, Tergaonkar V. Non-coding RNA-based regulation of inflammation. Semin Immunol 2022;:101606. [PMID: 35691882 DOI: 10.1016/j.smim.2022.101606] [Reference Citation Analysis]
4 Cook JJ, Wei M, Segovia B, Cosio-Lima L, Simpson J, Taylor S, Koh Y, Kim S, Lee Y. Endurance exercise-mediated metabolic reshuffle attenuates high-caloric diet-induced non-alcoholic fatty liver disease. Ann Hepatol 2022;:100709. [PMID: 35489641 DOI: 10.1016/j.aohep.2022.100709] [Reference Citation Analysis]
5 Sun H, Zhou Y, Ma R, Zhang J, Shan J, Chen Y, Li X, Shan E. Metformin protects 5-Fu-induced chemotherapy oral mucositis by reducing endoplasmic reticulum stress in mice. Eur J Pharm Sci 2022;:106182. [PMID: 35405270 DOI: 10.1016/j.ejps.2022.106182] [Reference Citation Analysis]
6 Zhang H, Niu Q, Liang K, Li X, Jiang J, Bian C. Effect of LncPVT1/miR-20a-5p on Lipid Metabolism and Insulin Resistance in NAFLD. Diabetes Metab Syndr Obes 2021;14:4599-608. [PMID: 34848984 DOI: 10.2147/DMSO.S338097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Suzuki H, Mitsunaga S, Ikeda M, Aoyama T, Yoshizawa K, Yoshimatsu H, Kawai N, Masuda M, Miura T, Ochiai A. Clinical and Tumor Characteristics of Patients with High Serum Levels of Growth Differentiation Factor 15 in Advanced Pancreatic Cancer. Cancers (Basel) 2021;13:4842. [PMID: 34638326 DOI: 10.3390/cancers13194842] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
8 Peng XF, Huang SF, Chen LJ, Xu L, Ye WC. Targeting epigenetics and lncRNAs in liver disease: From mechanisms to therapeutics. Pharmacol Res 2021;172:105846. [PMID: 34438063 DOI: 10.1016/j.phrs.2021.105846] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhang C, Yang M. The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma. Cancers (Basel) 2021;13:3740. [PMID: 34359642 DOI: 10.3390/cancers13153740] [Reference Citation Analysis]
10 Ahmad S, Abbas M, Ullah MF, Aziz MH, Beylerli O, Alam MA, Syed MA, Uddin S, Ahmad A. Long non-coding RNAs regulated NF-κB signaling in cancer metastasis: Micromanaging by not so small non-coding RNAs. Semin Cancer Biol 2021:S1044-579X(21)00210-8. [PMID: 34314819 DOI: 10.1016/j.semcancer.2021.07.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]